SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-009991
Filing Date
2013-01-11
Accepted
2013-01-11 06:12:06
Documents
13
Period of Report
2013-01-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d466170d8k.htm 8-K 16797
2 PORTION OF SLIDES AND RELATED TRANSCRIPT OF PRESENTATION d466170dex991.htm EX-99.1 34567
3 GRAPHIC g4661701.jpg GRAPHIC 163039
4 GRAPHIC g46617010.jpg GRAPHIC 205287
5 GRAPHIC g46617011.jpg GRAPHIC 169341
6 GRAPHIC g4661702.jpg GRAPHIC 391463
7 GRAPHIC g4661703.jpg GRAPHIC 315160
8 GRAPHIC g4661704.jpg GRAPHIC 178239
9 GRAPHIC g4661705.jpg GRAPHIC 169677
10 GRAPHIC g4661706.jpg GRAPHIC 150014
11 GRAPHIC g4661707.jpg GRAPHIC 133680
12 GRAPHIC g4661708.jpg GRAPHIC 165909
13 GRAPHIC g4661709.jpg GRAPHIC 210223
  Complete submission text file 0001193125-13-009991.txt   3156960
Mailing Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4
Business Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4 353-1-634-4183
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 13524138
SIC: 2834 Pharmaceutical Preparations